Cullinan Therapeutics Inc’s filing revealed that its Chief Scientific Officer Michaelson Jennifer unloaded Company’s shares for reported $0.13 million on Nov 05 ’24. In the deal valued at $15.64 per share,8,000 shares were sold. As a result of this transaction, Michaelson Jennifer now holds 107,942 shares worth roughly $1.38 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Michaelson Jennifer sold 8,000 shares, generating $144,720 in total proceeds. Upon selling the shares at $18.09, the Chief Scientific Officer now owns 115,942 shares.
Before that, JENNIFER MICHAELSON & MARC D M bought 16,000 shares. Cullinan Therapeutics Inc shares valued at $298,880 were divested by the Officer at a price of $18.68 per share.
UBS initiated its Cullinan Therapeutics Inc [CGEM] rating to a Buy in a research note published on October 24, 2024; the price target was $30. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. William Blair began covering CGEM with “an Outperform” recommendation on April 15, 2024. Wedbush started covering the stock on February 15, 2024. It rated CGEM as “an Outperform”.
Price Performance Review of CGEM
On Tuesday, Cullinan Therapeutics Inc [NASDAQ:CGEM] saw its stock fall -2.81% to $12.80. Over the last five days, the stock has gained 2.07%. Cullinan Therapeutics Inc shares have risen nearly 25.61% since the year began. Nevertheless, the stocks have risen 47.81% over the past one year. While a 52-week high of $30.19 was reached on 05/07/24, a 52-week low of $7.64 was recorded on 01/11/24. SMA at 50 days reached $15.50, while 200 days put it at $18.23.
Levels Of Support And Resistance For CGEM Stock
The 24-hour chart illustrates a support level at 12.42, which if violated will result in even more drops to 12.05. On the upside, there is a resistance level at 13.40. A further resistance level may holdings at 14.00. The Relative Strength Index (RSI) on the 14-day chart is 36.76, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.77%. Stochastics %K at 21.24% indicates the stock is a holding.
How much short interest is there in Cullinan Therapeutics Inc?
A steep rise in short interest was recorded in Cullinan Therapeutics Inc stocks on 2024-11-15, dropping by -0.35 million shares to a total of 8.71 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 9.06 million shares. There was a decline of -4.04%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 15, 2023 when TD Cowen began covering the stock and recommended ‘”an Outperform”‘ rating .
